Advertisement

Topics

Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial

13:32 EDT 22 Aug 2018 | Outsourcing-Pharma

The Canadian CDMO Dalton Pharma Services will manufacture Arch Biopartners' drug candidate for use in Phase I clinical trials.

Original Article: Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial

NEXT ARTICLE

More From BioPortfolio on "Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...